Mar 07, 2023 / 09:35PM GMT
Andrew Cooper - Raymond James - Analyst
Great. Welcome to one of the final Tuesday presentations of the Raymond James Institutional Investor Conference. I'm happy to be joined by Dorian LeBlanc from LumiraDx. Exciting opportunity and exciting platform here, I think, in point of care diagnostics. Really trying to change what's out there.
And with that, I will pass it over to Dorian for a presentation. Thanks, Dorian.
Dorian LeBlanc - LumiraDx Limited - CFO & VP, Global Operations
Great, Andrew. Thank you very much, and appreciate Raymond James giving us the opportunity to present here today and appreciate you all taking the time to learn more about the LumiraDx story. So for those of you who may not be as familiar with the company, this is our founders, forward start-up and point-of-care diagnostics. So Ron Zwanziger, Dave Scott, Jerry McAleer. Real pioneers in point-of-care diagnostics.
The first two companies in blood glucose. They launched the first electrochemical blood glucose analyzer that could be used by a patient at home. That
LumiraDx Ltd at Raymond James Institutional Investors Conference Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers